Credit Suisse Ag Taro Pharmaceutical Industries LTD Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Credit Suisse Ag holds 13,127 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,127

Previous 13,127 -0.0%

Holding current value

Previous $548,000 1.28%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$32.77 - $42.31 $48,958 - $63,211	1,494 Added 12.84%	13,127 $548,000
Q3 2023 Nov 13, 2023	SELL	$35.46 - $40.13 $17,800 - $20,145	-502 Reduced 4.14%	11,633 $438,000
Q2 2023 Aug 11, 2023	SELL	$24.24 - $40.97 $78,149 - $132,087	-3,224 Reduced 20.99%	12,135 $460,000
Q1 2023 May 10, 2023	SELL	$23.0 - $31.59 $644 - $884	-28 Reduced 0.18%	15,359 $373,000
Q4 2022 Feb 13, 2023	BUY	$27.6 - $32.99 $19,789 - $23,653	717 Added 4.89%	15,387 $446,000
Q3 2022 Nov 10, 2022	BUY	$28.74 - $39.9 $23,135 - $32,119	805 Added 5.81%	14,670 $440,000
Q2 2022 Aug 12, 2022	SELL	$35.0 - $43.59 $32,235 - $40,146	-921 Reduced 6.23%	13,865 $501,000
Q1 2022 May 16, 2022	BUY	$43.12 - $50.3 $27,122 - $31,638	629 Added 4.44%	14,786 $639,000
Q4 2021 Feb 14, 2022	SELL	$47.6 - $65.0 $39,746 - $54,275	-835 Reduced 5.57%	14,157 $709,000
Q3 2021 Nov 12, 2021	BUY	$62.34 - $73.38 $561 - $660	9 Added 0.06%	14,992 $954,000
Q2 2021 Aug 16, 2021	SELL	$70.26 - $76.64 $276,894 - $302,038	-3,941 Reduced 20.83%	14,983 $1.08 Million
Q1 2021 May 14, 2021	BUY	$70.48 - $79.95 $20,509 - $23,265	291 Added 1.56%	18,924 $1.4 Million
Q4 2020 Feb 12, 2021	BUY	$54.4 - $73.42 $1.01 Million - $1.37 Million	18,633 New	18,633 $1.37 Million
Q2 2020 Aug 12, 2020	SELL	$61.66 - $70.16 $298,742 - $339,925	-4,845 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$59.35 - $88.73 $287,550 - $429,896	4,845 New	4,845 $296,000
Q3 2019 Nov 12, 2019	SELL	$75.36 - $86.57 $178,301 - $204,824	-2,366 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$83.92 - $108.88 $34,826 - $45,185	415 Added 21.27%	2,366 $203,000
Q1 2019 May 14, 2019	BUY	$85.97 - $108.09 $167,727 - $210,883	1,951 New	1,951 $211,000
Q4 2018 Feb 13, 2019	SELL	$78.25 - $107.92 $308,461 - $425,420	-3,942 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$97.82 - $116.09 $224,594 - $266,542	-2,296 Reduced 36.81%	3,942 $388,000
Q2 2018 Aug 14, 2018	BUY	$97.62 - $120.59 $608,953 - $752,240	6,238 New	6,238 $721,000
Q1 2018 May 15, 2018	SELL	$95.91 - $107.26 $932,724 - $1.04 Million	-9,725 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$104.5 - $126.38 $621,357 - $751,455	-5,946 Reduced 37.94%	9,725 $1.02 Million
Q3 2017 Nov 14, 2017	BUY	$97.26 - $116.2 $73,139 - $87,382	752 Added 5.04%	15,671 $1.77 Million
Q2 2017 Aug 14, 2017	BUY	N/A	14,919	14,919 $1.67 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account